A citation-based method for searching scientific literature

Leilei Chen, Yan Li, Chi Ho Lin, Tim Hon Man Chan, Raymond Kwok Kei Chow, Yangyang Song, Ming Liu, Yun-Fei Yuan, Li Fu, Kar Lok Kong, Lihua Qi, Yan Li, Na Zhang, Amy Hin Yan Tong, Dora Lai-Wan Kwong, Kwan Man, Chung Mau Lo, Si Lok, Daniel G Tenen, Xin-Yuan Guan. Nat Med 2013
Times Cited: 285



Jochen C Hartner, Carolin Schmittwolf, Andreas Kispert, Albrecht M Müller, Miyoko Higuchi, Peter H Seeburg. J Biol Chem 2004
Times Cited: 306




List of shared articles



Times cited

To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
Emily A Erdmann, Ananya Mahapatra, Priyanka Mukherjee, Boyoon Yang, Heather A Hundley. Crit Rev Biochem Mol Biol 2021
0

Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
Pamela R de Santiago, Alejandro Blanco, Fernanda Morales, Katherine Marcelain, Olivier Harismendy, Marcela Sjöberg Herrera, Ricardo Armisén. Life Sci 2021
2

The effects of RNA editing in cancer tissue at different stages in carcinogenesis.
Małgorzata Kurkowiak, Łukasz Arcimowicz, Elżbieta Chruściel, Zuzanna Urban-Wójciuk, Ines Papak, Liam Keegan, Mary O'Connell, Jacek Kowalski, Ted Hupp, Natalia Marek-Trzonkowska. RNA Biol 2021
1

A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects.
Heming Wang, Sinuo Chen, Jiayi Wei, Guangqi Song, Yicheng Zhao. Front Oncol 2021
1

Systematic identification of A-to-I RNA editing in zebrafish development and adult organs.
Ilana Buchumenski, Karoline Holler, Lior Appelbaum, Eli Eisenberg, Jan Philipp Junker, Erez Y Levanon. Nucleic Acids Res 2021
0

The role of RNA editing enzyme ADAR1 in human disease.
Brian Song, Yusuke Shiromoto, Moeko Minakuchi, Kazuko Nishikura. Wiley Interdiscip Rev RNA 2021
2

A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Pedro Henrique Costa Cruz, Yuki Kato, Taisuke Nakahama, Toshiharu Shibuya, Yukio Kawahara. RNA 2020
6

Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Taisuke Nakahama, Yukio Kawahara. Cell Mol Life Sci 2020
6

Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma.
Xiang Yi Kong, Erik Sebastian Vik, Meh Sameen Nawaz, Natalia Berges, Tuva Børresdatter Dahl, Cathrine Vågbø, Rajikala Suganthan, Filip Segers, Sverre Holm, Ana Quiles-Jiménez,[...]. Nucleic Acids Res 2020
3

Systematic identification of A-to-I editing associated regulators from multiple human cancers.
Tongjun Gu, Audrey Qiuyan Fu, Michael J Bolt, Xiwu Zhao. Comput Biol Med 2020
0


RNA editing in mesothelioma: a look forward.
Ananya Hariharan, Suna Sun, Martin Wipplinger, Emanuela Felley-Bosco. Open Biol 2020
1

Inosine induces context-dependent recoding and translational stalling.
Konstantin Licht, Markus Hartl, Fabian Amman, Dorothea Anrather, Michael P Janisiw, Michael F Jantsch. Nucleic Acids Res 2019
41

RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing.
Genghao Chen, Dhruva Katrekar, Prashant Mali. Biochemistry 2019
7

Defining the functions of adenosine-to-inosine RNA editing through hematology.
Jacki E Heraud-Farlow, Alistair M Chalk, Carl R Walkley. Curr Opin Hematol 2019
1


ADAR1: "Editor-in-Chief" of Cytoplasmic Innate Immunity.
Mart M Lamers, Bernadette G van den Hoogen, Bart L Haagmans. Front Immunol 2019
40

The Editor's I on Disease Development.
Mamta Jain, Michael F Jantsch, Konstantin Licht. Trends Genet 2019
11

The majority of A-to-I RNA editing is not required for mammalian homeostasis.
Alistair M Chalk, Scott Taylor, Jacki E Heraud-Farlow, Carl R Walkley. Genome Biol 2019
14

ADAR, the carcinogenesis mechanisms of ADAR and related clinical applications.
Yue Zhang, Huizhu Qian, Jing Xu, Wen Gao. Ann Transl Med 2019
5